755 filings
Page 36 of 38
ARS
2013 FY
AERI
Aerie Pharmaceuticals Inc
5 May 14
Annual report to shareholders
12:00am
DEF 14A
AERI
Aerie Pharmaceuticals Inc
30 Apr 14
Definitive proxy
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
9 Apr 14
Any discussion of the potential use or expected success of our product candidates is subject to our
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
2 Apr 14
Aerie Pharmaceuticals to Present at the 13th Annual Needham Healthcare Conference
12:00am
10-K
2013 FY
AERI
Aerie Pharmaceuticals Inc
26 Mar 14
Annual report
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
19 Mar 14
Departure of Directors or Certain Officers
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
18 Mar 14
Provides Business and Product Development Update
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
5 Mar 14
Aerie Pharmaceuticals to Present at the 26th Annual ROTH Conference
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
27 Feb 14
Aerie Pharmaceuticals to Present at the Cowen and Company 34th Annual Health Care Conference
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
26 Feb 14
Any discussion of the potential use or expected success of our product candidates is subject to our
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
25 Feb 14
Aerie Pharmaceuticals Announces Study Results Supporting Additional Mechanism of Action for Lead Glaucoma Drug Candidate AR-13324
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
19 Feb 14
Aerie Pharmaceuticals to Present at the RBC Capital Markets Global Healthcare Conference
12:00am
SC 13G
AERI
Aerie Pharmaceuticals Inc
14 Feb 14
Aerie Pharmaceuticals Inc
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
30 Jan 14
Regulation FD Disclosure
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
27 Jan 14
Any discussion of the potential use or expected success of our product candidates is subject to our product
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
9 Jan 14
Aerie Pharmaceuticals Reports Positive Results for Lead Candidate AR-13324 in Normotensive Individuals
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
20 Dec 13
Departure of Directors or Certain Officers
12:00am
10-Q
2013 Q3
AERI
Aerie Pharmaceuticals Inc
5 Dec 13
Quarterly report
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
4 Dec 13
Provides Business and Product Development Update
12:00am
SC 13D
Acp Iv L P
12 Nov 13
Beneficial ownership report
12:00am